Clinical TrialID 6734
Acceleration and Relapse Prevention With Triiodothyronine (T3) as an Adjunct to Electroconvulsive Therapy (ECT)
NCT01299337
Depression
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6734
- Evidence Id
- 6734
- Core Evidence Id
- 6734
- Source Clinical Trial Id
- 6722
- Herb2 Clinical Trial Id
- HBCT006722
- Nct Id
- NCT01299337
- Title
- Acceleration and Relapse Prevention With Triiodothyronine (T3) as an Adjunct to Electroconvulsive Therapy (ECT)
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Depression
- Study Type
- Observational
- Study Design
- Observational Model: |Time Perspective: p
- Intervention
- DRUG: T3
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Gender
- All
- Age
- Adult
- Enrollment
- 29
- Outcome Measure
- To determine if people get better faster and stay better longer using T3 as adjunct to ECT., Phase A and Phase B
- Sponsor Collaborator
- Mayo Clinic
- Funded By
- OTHER
- Location
- Mayo Clinic Department of Psychiatry and Psychology, Rochester, Minnesota, 55904, United States
- Other Id
- 07-004759
- Start Date
- 2008-06
- Primary Completion Date
- 2012-04
- Completion Date
- 2012-04
- First Posted
- 2011-02-18
- Results First Posted
- Last Update Posted
- 2012-05-11
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01299337
- Title Cn
- Title En
- Acceleration and Relapse Prevention With Triiodothyronine (T3) as an Adjunct to Electroconvulsive Therapy (ECT)
- Bilingual Status
- semi_complete